Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Pandemrix

- PMLiVE

GSK and J&J file sirukumab for rheumatoid arthritis in EU

If approved it will compete with Roche blockbuster Actemra

- PMLiVE

EMA suspends generic drugs on data integrity concerns

Reports by FDA and WHO find evidence of data manipulation by Semler Research Centre

- PMLiVE

GSK launches first pharma trial powered by Apple’s ResearchKit

Will use an iPhone app built using the software for a real-world study

- PMLiVE

Hanover Comms collects Excellence in Public Health Comms award

Communiqué judges praise the #Savethemale campaign’s “sensitive” approach

- PMLiVE

CDC says no to AZ’s intranasal flu vaccine FluMist

US government data reports “poor” efficacy for the injected vaccine alternative

- PMLiVE

GSK signs up for the ‘dawn of cognitive advertising’

Its consumer health arm is among the first to use new IBM offering Watson Ads

- PMLiVE

GSK’s chief executive Sir Andrew Witty to retire next year

The announcement follows months of speculation about his position

AstraZeneca AZ global R&D corporate HQ

AZ’s influenza drug fast tracked in US

FDA expedites MEDI8852 to help meet an acute need for new flu treatments

- PMLiVE

GSK appoints rare diseases research head

Birgitte Volck moves to the company from Swedish Ophan Biovitrum

- PMLiVE

GSK plans sirukumab filing in rheumatoid arthritis next year

Says phase III trials showed 'no unexpected safety findings'

dengue fever mosquito

Sanofi gets first approval for dengue vaccine

Wins green light for Dengvaxia in Mexico

- PMLiVE

GSK’s severe asthma therapy Nucala gets EU nod

Becomes the first IL-5 inhibitor to be approved in the EU

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links